Dyslipidaemia and coagulation defects of insulin resistance

International Journal of Clinical Practice, Supplement

Volumn , Issue 113, 2000, Pages 14-22

  Frohlich, J ^a   Steiner, G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTILIPEMIC AGENT; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTHROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; AGED; ATHEROGENESIS; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOCYTE ACTIVATION;

ANTILIPEMIC AGENTS; BLOOD COAGULATION DISORDERS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; HYPERLIPIDEMIAS; INSULIN RESISTANCE; RISK FACTORS;

EID: 0033663270     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Mortality in adults with and without diabetes in a national cohort of the U.S. population 1971-1993
2. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
3. Heart disease and diabetes
4. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: The Cardiovascular Health Study
5. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
6. Role of insulin resistance in human disease
7. Hyperinsulinemia in a population at high risk for non-insulin dependent diabetes mellitus
8. Group. XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects
9. Diabetes mellitus: Subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality
10. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose intolerance
11. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study
12. Regulation of apolipoprotein A-I containing lipoproteins in IDDM
13. HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus
14. Fractional esterification rate of HDL particles in patients with type 2 diabetes: Relation to coronary heart disease risk factors
15. Clinical relevance of the oxidative stress concept
16. Cardiovascular risk continuum: Implications of insulin resistance and diabetes
17. Dyslipidemia, morbidity and mortality in non-insulin-dependent diabetes mellitus
18. Assessment of atherogenic profile of plasma using estimation of cholesterol esterification in apolipoprotein B depleted plasma (FER(HDL)) and logarithmically transformed ratio of triglyceride/HDL-cholesterol
19. Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes
20. The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles
21. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: Subgroup analyses of the Scandinavian Simvastatin Survival Study
22. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: The Post Coronary Artery Bypass Graft Trial
23. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
24. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial
25. Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease
26. Gemfibrozil for the secondary prevention of coronary artery disease in men with low levels of high-density lipoprotein cholesterol
27. The Diabetes Atherosclerosis Intervention Study (DAIS): A study conducted in cooperation with the World Health Organization. The DAIS Project Group
28. Diabetes and cardiovascular disease
29. A review of metabolic and cardiovascular effects of oral antidiabetic agents: Beyond glucose-level lowering
30. Final report on the aspirin component of the ongoing Physicians' Health Study
31. Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells
32. Hyperinsulinemia, hyperglycemia and impaired hemostasis: The Framingham Offspring Study
33. Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group
34. Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: The Northern Sweden MONICA Study
35. Effects of fluvastatin on prothrombotic and fibrinolytic factors in type 2 diabetes mellitus
36. Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation - A preliminary report
37. Inhibition of heparin catalyzed human antithrombin III activity by nonenzymatic glycosylation: Possible role in fibrin deposition in diabetes
38. Increased platelet aggregation in early diabetes mellitus
39. Evidence for abnormal platelet glycoprotein expression in diabetes mellitus
40. Thromboxane biosynthesis and platelet function in type I diabetes mellitus
41. Thrombogenic factors and recurrent coronary events
42. Interaction of coagulation defects in cardiovascular risk factors
43. Insulin resistant pre-diabetic subjects have more atherogenic risk factors than insulin sensitive pre-diabetic subjects
44. Diabetes and decline in heart disease mortality in US adults